Antimicrobial Agents — MCQs
On this page
Which of the following is a new drug for the treatment of multidrug-resistant tuberculosis?
A 75-year-old male develops a cough producing blood-tinged sputum and a fever of 104°F. A sputum smear reveals Gram-positive cocci in clusters, and a chest x-ray shows increased density in the right upper lobe. Which of the following penicillins is most likely to be ineffective against this patient's likely pathogen?
Which antimalarial agent(s) should be avoided in pregnancy?
Which of the following antibiotics has the maximum auditory toxicity?
What is the drug of choice for late East African Trypanosomiasis?
What is the daily dose of isoniazid in the treatment of tuberculosis?
What is the drug of choice for actinomycosis?
Toxicity of Amphotericin B can be reduced by using which formulation?
What is the antibiotic of choice in patients with penicillin sensitivity?
What is the drug of choice for prophylaxis of meningococcal meningitis in a pregnant female after contact with a case?
Antimicrobial Agents Indian Medical PG Practice Questions and MCQs
Question 471: Which of the following is a new drug for the treatment of multidrug-resistant tuberculosis?
- A. Bedaquiline (Correct Answer)
- B. Linezolid
- C. Levofloxacin
- D. Cefepime
Explanation: **Explanation:** **Bedaquiline (Option A)** is the correct answer. It is a novel diarylquinoline antitubercular agent specifically approved for the treatment of multidrug-resistant tuberculosis (MDR-TB). Its unique mechanism of action involves the inhibition of **mycobacterial ATP synthase**, an enzyme essential for energy production in *Mycobacterium tuberculosis*. By targeting the proton pump of the ATP synthase, it effectively kills both actively replicating and dormant bacilli. **Analysis of Incorrect Options:** * **Linezolid (Option B):** While used as a "Group B" drug in MDR-TB regimens, it is an oxazolidinone antibiotic primarily used for Gram-positive infections (like MRSA). It is not a "new" drug specifically developed for TB, though it is highly effective. * **Levofloxacin (Option C):** This is a second-generation fluoroquinolone. While it is a cornerstone of MDR-TB treatment (Group A), it is an older class of drugs with broad-spectrum antibacterial activity. * **Cefepime (Option D):** This is a fourth-generation cephalosporin. It has no clinical activity against *M. tuberculosis* and is used for systemic Gram-negative infections. **High-Yield Clinical Pearls for NEET-PG:** * **Black Box Warning:** Bedaquiline can cause **QT interval prolongation**; therefore, ECG monitoring is mandatory. * **Metabolism:** It is metabolized by **CYP3A4**; co-administration with rifampin (a potent inducer) should be avoided. * **Other New Drugs:** Along with Bedaquiline, **Pretomanid** and **Delamanid** (nitroimidazoles) are other recent additions to the MDR-TB/XDR-TB armamentarium. * **BPaL Regimen:** A modern, highly effective regimen for XDR-TB consisting of **B**edaquiline, **P**retomanid, and **L**inezolid.
Question 472: A 75-year-old male develops a cough producing blood-tinged sputum and a fever of 104°F. A sputum smear reveals Gram-positive cocci in clusters, and a chest x-ray shows increased density in the right upper lobe. Which of the following penicillins is most likely to be ineffective against this patient's likely pathogen?
- A. Oxacillin
- B. Cloxacillin
- C. Ticarcillin (Correct Answer)
- D. Nafcillin
Explanation: **Explanation:** **1. Analysis of the Clinical Scenario:** The patient presents with symptoms of pneumonia (fever, cough, blood-tinged sputum). The key diagnostic clue is the sputum smear showing **Gram-positive cocci in clusters**, which is pathognomonic for ***Staphylococcus aureus***. Most community and hospital strains of *S. aureus* produce **penicillinase** (a type of $\beta$-lactamase), making them resistant to standard penicillins like Penicillin G and Aminopenicillins. **2. Why Ticarcillin is the Correct Answer:** **Ticarcillin** is a carboxypenicillin categorized as an **Antipseudomonal penicillin**. While it has excellent activity against Gram-negative rods (like *Pseudomonas aeruginosa*), it is **susceptible to degradation by staphylococcal penicillinase**. Therefore, it is ineffective against penicillinase-producing *S. aureus* unless combined with a $\beta$-lactamase inhibitor (e.g., Clavulanic acid). **3. Why the Other Options are Incorrect:** * **Oxacillin, Cloxacillin, and Nafcillin** belong to the class of **Antistaphylococcal penicillins**. These drugs possess bulky side chains that sterically hinder the action of staphylococcal $\beta$-lactamase. They are the drugs of choice for Methicillin-Sensitive *Staphylococcus aureus* (MSSA). **High-Yield Clinical Pearls for NEET-PG:** * **DOC for MSSA:** Nafcillin (IV) or Cloxacillin (Oral). * **MRSA Mechanism:** Resistance is due to an altered target site (**PBP-2a**), encoded by the ***mecA* gene**, not $\beta$-lactamase production. Therefore, even antistaphylococcal penicillins fail against MRSA. * **Antipseudomonal Penicillins:** Include Carboxypenicillins (Ticarcillin, Carbenicillin) and Ureidopenicillins (Piperacillin). Remember: "Piperacillin is the most potent among these."
Question 473: Which antimalarial agent(s) should be avoided in pregnancy?
- A. Chloroquine
- B. Quinine
- C. Primaquine (Correct Answer)
- D. Anti-folates and Tetracyclines
Explanation: The correct answer is **Primaquine**. **Why Primaquine is avoided:** Primaquine is strictly contraindicated throughout pregnancy [1]. The primary concern is that the drug can cross the placenta and reach the fetus. If the fetus is **Glucose-6-Phosphate Dehydrogenase (G6PD) deficient**, Primaquine can induce severe **fetal hemolysis**, leading to intrauterine anemia and potential fetal demise [1]. Since the G6PD status of a fetus cannot be safely determined in utero, the drug is withheld until after delivery. **Analysis of other options:** * **Chloroquine:** It is considered the drug of choice for sensitive *P. falciparum* and *P. vivax* during all trimesters of pregnancy [1]. It is safe and non-teratogenic. * **Quinine:** It is the mainstay of treatment for severe malaria or chloroquine-resistant malaria in the first trimester. While high doses can be oxytocic, therapeutic doses are safe. * **Anti-folates (e.g., Sulfadoxine-Pyrimethamine):** These are used for Intermittent Preventive Treatment (IPTp) in the second and third trimesters. **Tetracyclines** (Doxycycline) are indeed avoided in pregnancy due to effects on fetal bones and teeth [1], but since the question asks for the most definitive "antimalarial agent" (singular/primary focus) and Primaquine carries the specific risk of fetal hemolysis, Primaquine remains the most classic contraindication in this context. **NEET-PG High-Yield Pearls:** * **Tafenoquine**, like Primaquine, is also contraindicated in pregnancy due to G6PD-related hemolysis risks. * **Artemisinin-based Combination Therapy (ACT):** Now recommended by the WHO as first-line treatment for uncomplicated malaria in **all trimesters**, including the first. * **Radical Cure:** For *P. vivax* in pregnancy, treat the acute attack with Chloroquine and defer Primaquine (radical cure for hypnozoites) until after the mother has finished breastfeeding [1].
Question 474: Which of the following antibiotics has the maximum auditory toxicity?
- A. Streptomycin
- B. Kanamycin
- C. Tobramycin
- D. Amikacin (Correct Answer)
Explanation: ### Explanation Aminoglycosides are notorious for their dose-dependent and duration-dependent **ototoxicity**, which can manifest as either **vestibular damage** (balance issues) or **cochlear damage** (hearing loss). This toxicity occurs due to the accumulation of the drug in the perilymph and endolymph, leading to the destruction of sensory hair cells. **Why Amikacin is the correct answer:** While all aminoglycosides can cause both types of damage, they exhibit a preference for one over the other. **Amikacin** and **Kanamycin** are the most potent **cochleotoxic** agents in this class. Among the options provided, Amikacin is clinically recognized for having the **maximum auditory toxicity**, often leading to irreversible high-frequency hearing loss. **Analysis of Incorrect Options:** * **Streptomycin:** Primarily **vestibulotoxic**. It is more likely to cause vertigo and nystagmus than hearing loss. * **Kanamycin:** Highly cochleotoxic, but in modern clinical practice and standardized competitive exams, Amikacin is cited as having the highest potential for auditory damage. * **Tobramycin:** Similar to Gentamicin, it affects both systems but is predominantly **vestibulotoxic**. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Ototoxicity:** * **Cochleotoxic (Hearing):** **A**mikacin, **K**anamycin, **N**eomycin (Mnemonic: **AKN** - "A"uditory). * **Vestibulotoxic (Balance):** **S**treptomycin, **G**entamicin (Mnemonic: **SG** - "S"haking). * **Nephrotoxicity:** **Neomycin** is the most nephrotoxic (hence used only topically/orally), while **Streptomycin** is the least. * **Neuromuscular Blockade:** Aminoglycosides can worsen Myasthenia Gravis; **Neomycin** is the most potent blocker, while **Tobramycin** is the least. * **Monitoring:** Ototoxicity is often irreversible; therefore, baseline and periodic audiometry are recommended during prolonged therapy.
Question 475: What is the drug of choice for late East African Trypanosomiasis?
- A. Pentamidine
- B. Suramine
- C. Melarsoprol (Correct Answer)
- D. Nifurtimox
Explanation: **Explanation:** The treatment of African Trypanosomiasis (Sleeping Sickness) is determined by the species (*T. brucei gambiense* vs. *rhodesiense*) and the stage of the disease (Early/Hemic-lymphatic vs. Late/Meningoencephalitic). **Why Melarsoprol is correct:** **Melarsoprol** is the drug of choice for **late-stage East African Trypanosomiasis** (*T. b. rhodesiense*). In the late stage, the parasite crosses the blood-brain barrier (BBB). Melarsoprol is an organic arsenical compound that is highly lipid-soluble, allowing it to achieve therapeutic concentrations in the CNS to kill the parasites. **Analysis of Incorrect Options:** * **Pentamidine (A):** Used for the **early stage** of West African Trypanosomiasis (*T. b. gambiense*). It does not cross the BBB. * **Suramin (B):** The drug of choice for the **early stage** of East African Trypanosomiasis (*T. b. rhodesiense*). Like pentamidine, it lacks CNS penetration. * **Nifurtimox (D):** Primarily used for **Chagas disease** (American Trypanosomiasis). It is also used in combination with Eflornithine (NECT) for late-stage West African Trypanosomiasis, but not as monotherapy for the East African variety. **High-Yield Clinical Pearls for NEET-PG:** 1. **Toxicity:** Melarsoprol is highly toxic; the most feared side effect is **reactive encephalopathy** (seen in 5-10% of patients), which can be fatal. 2. **West vs. East:** Remember **"EAR"** for East African = **S**uramin (Early) and **M**elarsoprol (Late). 3. **Eflornithine:** Known as the "resurrection drug," it is the drug of choice for late-stage West African Trypanosomiasis but is **ineffective** against the East African species.
Question 476: What is the daily dose of isoniazid in the treatment of tuberculosis?
- A. 5 mg/kg body weight (Correct Answer)
- B. 10 mg/kg body weight
- C. 20 mg/kg body weight
- D. 15 mg/kg body weight
Explanation: **Explanation:** The standard daily dose of **Isoniazid (INH)** for the treatment of tuberculosis in adults is **5 mg/kg body weight** (maximum 300 mg per day). This dosage is optimized to maintain therapeutic efficacy while minimizing the risk of dose-dependent toxicity. **Why Option A is correct:** Isoniazid is a bactericidal drug that inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. At a dose of 5 mg/kg, it achieves plasma concentrations significantly higher than the Minimum Inhibitory Concentration (MIC) for *M. tuberculosis*, effectively killing rapidly dividing intra- and extracellular bacilli. **Why other options are incorrect:** * **Option B (10 mg/kg):** This is the standard daily dose for **Rifampicin** (up to 600 mg) and is also the recommended dose for Isoniazid in **pediatric patients** (10–15 mg/kg) due to their faster metabolism. * **Options C & D (15-20 mg/kg):** These doses are excessively high for daily administration in adults and would significantly increase the risk of hepatotoxicity and peripheral neuropathy. However, 15 mg/kg is sometimes used in intermittent (thrice-weekly) supervised regimens. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits *inhA* and *kasA* enzymes involved in mycolic acid synthesis; it is a **prodrug** activated by the mycobacterial **KatG** enzyme. * **Adverse Effects:** 1. **Peripheral Neuropathy:** Caused by interference with Pyridoxine (Vitamin B6) metabolism. Always co-prescribe **10–50 mg/day of Vitamin B6**. 2. **Hepatotoxicity:** The most common serious side effect; risk increases with age and alcohol use. * **Metabolism:** Occurs via **Acetylation** (Genetic polymorphism: Fast vs. Slow acetylators). Slow acetylators are more prone to neuropathy. * **Drug of Choice:** For Latent TB infection (Chemoprophylaxis).
Question 477: What is the drug of choice for actinomycosis?
- A. Penicillin (Correct Answer)
- B. Sulfonamides
- C. Tetracycline
- D. Azithromycin
Explanation: **Explanation:** **Actinomycosis** is a chronic, granulomatous infection caused by *Actinomyces israelii*, a Gram-positive, anaerobic, non-acid-fast branching filamentous bacterium. **1. Why Penicillin is the Correct Answer:** **Penicillin G** (intravenous) followed by **Penicillin V** (oral) is the definitive **drug of choice**. *Actinomyces* species are exquisitely sensitive to beta-lactams. Because the infection is characterized by dense fibrosis and "sulfur granules" (microcolonies) which limit drug penetration, high-dose, prolonged therapy (6–12 months) is required to prevent relapse. **2. Analysis of Incorrect Options:** * **Sulfonamides (B):** While historically used, they are significantly less effective than Penicillin and are not considered first-line. They are primarily used for *Nocardia* (which is acid-fast), often leading to confusion between the two. * **Tetracycline/Doxycycline (C):** These are considered **second-line** agents or the drug of choice only in patients with a **Penicillin allergy**. * **Azithromycin (D):** Macrolides have some activity but are not standard therapy and lack the robust clinical evidence supporting Penicillin or Tetracyclines for this specific infection. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Lumpy Jaw":** The most common presentation is cervicofacial actinomycosis, often following dental procedures or poor oral hygiene. * **Sulfur Granules:** A hallmark diagnostic finding in abscess pus (yellowish specks), though they do not actually contain sulfur. * **Differential Diagnosis:** Always distinguish from *Nocardia*. * *Actinomyces*: Anaerobic, Non-acid-fast, Rx: **Penicillin**. * *Nocardia*: Aerobic, Weakly acid-fast, Rx: **Cotrimoxazole**. * **IUD Association:** Pelvic actinomycosis is strongly associated with the long-term use of intrauterine contraceptive devices.
Question 478: Toxicity of Amphotericin B can be reduced by using which formulation?
- A. Liquid preparation
- B. Granules
- C. Liposomal preparation (Correct Answer)
- D. Subcutaneous administration
Explanation: **Explanation:** **Amphotericin B** is a potent antifungal that acts by binding to ergosterol in fungal cell membranes, creating pores that lead to cell death. However, it also binds to cholesterol in human cell membranes, leading to significant toxicity—most notably **nephrotoxicity** (azotemia, renal tubular acidosis, and potassium/magnesium wasting). **Why Liposomal Preparation is Correct:** Liposomal Amphotericin B (L-AMB) is a lipid-based formulation where the drug is encapsulated within phospholipid vesicles. This delivery system acts as a "reservoir." It has a higher affinity for fungal ergosterol than human cholesterol and preferentially distributes to the reticuloendothelial system (liver and spleen) rather than the kidneys. This significantly **reduces nephrotoxicity** and infusion-related reactions (fever, chills) while allowing for higher dosing. **Analysis of Incorrect Options:** * **A & B (Liquid/Granules):** These refer to standard oral or systemic forms. Conventional Amphotericin B (Deoxycholate) is a colloidal suspension, but it is the most toxic form. Granules are not a standard delivery method for systemic fungal infections. * **D (Subcutaneous):** Amphotericin B is highly irritating to tissues and is not absorbed well via the subcutaneous route. It must be given intravenously for systemic infections. **Clinical Pearls for NEET-PG:** * **Dose-limiting toxicity:** Nephrotoxicity is the primary concern with the conventional form. * **Lipid Formulations:** Include Liposomal (AmBisome), Lipid Complex (ABLC), and Colloidal Dispersion (ABCD). * **Pre-medication:** To prevent infusion reactions, patients are often given antipyretics, antihistamines, or corticosteroids. * **Hydration:** Saline loading (500mL–1L) before infusion helps mitigate renal damage.
Question 479: What is the antibiotic of choice in patients with penicillin sensitivity?
- A. Erythromycin (Correct Answer)
- B. Streptomycin
- C. Tetracycline
- D. Chloramphenicol
Explanation: The correct answer is **Erythromycin**. **Why Erythromycin is the correct choice:** Erythromycin, a macrolide antibiotic, is classically considered the first-line alternative for patients with a documented **Type-I hypersensitivity (allergy) to Penicillin** [1]. This is because Erythromycin shares a similar antimicrobial spectrum with Penicillin G (targeting primarily Gram-positive cocci and bacilli), but it is chemically unrelated to beta-lactams. Therefore, there is no cross-reactivity, making it safe for penicillin-sensitive individuals in treating infections like streptococcal pharyngitis [2], diphtheria [3], and syphilis. **Analysis of incorrect options:** * **Streptomycin:** This is an aminoglycoside primarily used for tuberculosis and certain Gram-negative infections. It does not cover the typical Gram-positive spectrum of penicillin and carries risks of ototoxicity and nephrotoxicity. * **Tetracycline:** While broad-spectrum, it is bacteriostatic and has a different clinical profile. It is not the preferred substitute for routine penicillin-indicated infections due to widespread resistance and side effects (e.g., effects on teeth and bones). * **Chloramphenicol:** Though broad-spectrum, its use is severely restricted due to the risk of life-threatening bone marrow suppression (Aplastic Anemia) and Gray Baby Syndrome. It is never a first-line alternative for simple penicillin sensitivity. **NEET-PG High-Yield Pearls:** * **Cross-Reactivity:** Patients with penicillin allergy have a **5-10% risk** of cross-reactivity with first-generation Cephalosporins. However, Macrolides (Erythromycin, Azithromycin) have **zero** cross-reactivity. * **Drug of Choice (DOC):** Erythromycin is the DOC for *Legionella*, *Mycoplasma pneumoniae*, and *Diphtheria* (carriers and cases). * **Side Effect:** Erythromycin is a motilin agonist; it can cause epigastric pain and is sometimes used off-label for gastroparesis.
Question 480: What is the drug of choice for prophylaxis of meningococcal meningitis in a pregnant female after contact with a case?
- A. Ciprofloxacin
- B. Ceftriaxone (Correct Answer)
- C. Cefalexin
- D. Rifabutin
Explanation: **Explanation:** The goal of post-exposure prophylaxis (PEP) for meningococcal meningitis (*Neisseria meningitidis*) is to eradicate nasopharyngeal carriage in close contacts to prevent invasive disease and further transmission. **Why Ceftriaxone is the Correct Choice:** In the general population, **Rifampin** (or Ciprofloxacin) is typically the drug of choice. However, in **pregnant females**, Rifampin is avoided due to potential teratogenicity (though evidence is limited, safer alternatives exist). **Ceftriaxone (250 mg IM single dose)** is the drug of choice for pregnant women because it is highly effective at eradicating the carrier state and has an excellent safety profile (Category B) during pregnancy. **Analysis of Incorrect Options:** * **A. Ciprofloxacin:** While a common single-dose oral option for adults, it is generally avoided in pregnancy due to concerns regarding fetal cartilage damage (arthropathy). * **C. Cefalexin:** This is a first-generation cephalosporin. It does not achieve adequate concentrations in the nasopharyngeal mucosa or cross the blood-brain barrier effectively enough to be used for meningococcal prophylaxis. * **D. Rifabutin:** While related to Rifampin, it is primarily used for *Mycobacterium avium* complex (MAC) prophylaxis in HIV patients and is not the standard of care for meningococcal PEP. **High-Yield Clinical Pearls for NEET-PG:** * **Standard DOC for PEP:** Rifampin (600 mg BID for 2 days). * **Alternative for Adults:** Ciprofloxacin (500 mg single oral dose). * **DOC for Pregnancy/Children:** Ceftriaxone (250 mg IM single dose). * **Close Contacts Defined:** Household members, daycare center contacts, or anyone directly exposed to the patient's oral secretions (e.g., kissing, intubation) within 7 days before symptom onset.
Practice by Chapter
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free